• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Immunostimulant
    3 Drugs classified under this drug class

    All the Drug Class Drugs

    full basket chart

    Immunostimulant. Mifamurtide 4 mg/vial.
    VIAL (pwdr. for concentrate. for dispers. for infus.): 1×4 mg. After reconstit. to final volum. of 50 ml, each ml of suspens. contains 0.08 mg mifamurtide.
    Pts. 2-30 yrs.: 2 mg/m2 bdy. surf. As adjuvant ther. follow. resect.: twice wkly. at least 3 d apart for 12 wks., follow. by once wkly. tmts. for an addit. 24 wks. for a total of 48 infus in 36 wks. For special populat. See lit.
    Tmt. in child., adolesc. & young adult. with. high grade, resectab., nonmetastat. osteosarcoma aft. macroscopic. Complete surg. resect. In combinat. with post-op. multi-agent chemother. Safety and effic. assessed in pts. 2-30 yrs at init. diagn.
    C/I: Hypersens., Concurr. use with cyclosporine/other calcineurin inhibit., high-dose NSAIDs, cyclooxygenase inhibit.

    partial basket chart

    Immunostimulant. Plerixafor 24 mg / 1.2 ml.
    VIAL: 1. 0.24 mg/kg bdy weight/ dly,
    admin S.C. inject. 6-11 hrs prior to
    initiat. of apheresis follow. 4 day pretmt.
    with granulocyte-colony stimulat.
    factor (G-CSF).
    In combinat. with G-CSF to enhance
    mobilisat. hematopiet. stem cells to
    periph. blood for collect. and subseq.
    autologous transplant. in pts. with
    lymphoma and multiple myeloma.
    C/I: Hypersens.

    not in the basket chart

    Immunostimulant. Bacillus Calmette-Guérin (BCG) 2-8X10^8 CFU.
    VIAL: 1, 3. See lit.
    Tmt. flat urothelial cell carcinoma in situ
    (CIS) of the bladder, adjuv. ther. aft.
    transurethral resect. (TUR) of a primary or relaps. fic. papill. urothelial cell carcinoma
    of the bladder stage Ta (grade 2 or 3) or T1
    (grade 1, 2, 3). See lit. Maint. tmt. all pts:
    Wkly instill. for 3 consec. wks at mths 3, 6
    and 12 aft. initiat. See lit.